Analyst consensus rating
Lucid Diagnostics Analyst Rating: none
Direct answer
Lucid Diagnostics's consensus rating is none.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.00.
Forecast evidence checked October 19, 2026.
Get free Lucid Diagnostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.48
- Average price target
- $4.00
- High price target
- $9.50
- Low price target
- $2.00
- Low target gap
- +318.4%
- Target upside
- +736.8%
- High target gap
- +1,887.4%
- Target range width
- 1,569%
- Consensus rating
- none
- Analysts
- 5
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Lucid Diagnostics?
Lucid Diagnostics has a verified none consensus. The same dataset has an average price target of $4.00.
How far are Lucid Diagnostics's low and high targets from the recorded price?
The low target implies +318.4%, while the high target implies +1,887.4%.
How many analysts are included in Lucid Diagnostics's consensus?
The verified consensus includes 5 analysts.
How is Lucid Diagnostics's target upside or downside calculated?
The average target of $4.00 is divided by the recorded price of $0.48, then one is subtracted to produce +736.8%. This does not guarantee a future return.
When was Lucid Diagnostics's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.